Giannis Socrates Mountzios

26PUBLICATIONS
193CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jul 14, 2026
Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non-Small Cell Lung Cancer: Insights From the EVOKE-01 Study.

|Mar 28, 2026
Artificial Intelligence in ALK-Rearranged NSCLC: Forecasting Response and Resistance.

Andreas Koulouris, Christos Tsagkaris, Konstantinos Kalaitzidis

|Feb 13, 2026
Neoadjuvant, Adjuvant and Perioperative Treatment in Early-Stage Non-Small Cell Lung Cancer (NSCLC) with Actionable Genomic Alterations: Current Landscape and Future Perspectives.

Prodromos Koutoukoglou, Giannis Mountzios

|Feb 03, 2026
SNF-CLIMEDIN: A Randomized Trial of Digital Support and Intervention in Patients With Advanced Non-Small Cell Lung Cancer. A Hellenic Cooperative Oncology Group Study.

Paris A Kosmidis, Thanos Kosmidis, Kyriaki Papadopoulou

|Dec 30, 2025
Real-World Neoadjuvant Systemic Therapy Utilization and Treatment Patterns in Patients with Early-Stage or Locally Advanced Triple-Negative Breast Cancer in Greece-The TRINITY Study.

Konstantinos Papazisis, Christos Christodoulou, Flora Zagouri

|Sep 29, 2025
Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry.

Alessio Cortellini, Valentina Santo, Leonardo Brunetti

Pageof 5

Frequent Collaborators

4 joint publications

Marina-Chiara Garassino

3 joint publications

So Yeon Kim

3 joint publications

Elena Fountzilas

3 joint publications

Biagio Ricciuti